Banerjee, PJ;
Woodcock, MG;
Bunce, C;
Scott, R;
Charteris, DG;
(2013)
A pilot study of intraocular use of intensive anti-inflammatory; triamcinolone acetonide to prevent proliferative vitreoretinopathy in eyes undergoing vitreoretinal surgery for open globe trauma; the Adjuncts in Ocular Trauma (AOT) Trial: study protocol for a randomised controlled trial.
Trials
, 14
, Article 42. 10.1186/1745-6215-14-42.
![[thumbnail of 1745-6215-14-42.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png) Preview |
PDF
1745-6215-14-42.pdf Download (317kB) |
Abstract
Eyes sustaining open globe trauma (OGT) is a group at high risk of severe visual impairment. Proliferative vitreoretinopathy (PVR) is the commonest cause of retinal redetachment in these eyes and is reported to occur in up to 45% of cases. Intensive anti-inflammatory agents have been shown to be effective at modifying experimental PVR and to be well tolerated clinically.The Adjuncts in Ocular Trauma (AOT) Trial was designed to investigate the benefits of using intensive anti-inflammatory agents (intravitreal and sub-Tenon's triamcinolone, oral flurbiprofen and guttae prednisolone 1.0%) perioperatively in patients undergoing vitrectomy surgery following open globe trauma.
| Type: | Article |
|---|---|
| Title: | A pilot study of intraocular use of intensive anti-inflammatory; triamcinolone acetonide to prevent proliferative vitreoretinopathy in eyes undergoing vitreoretinal surgery for open globe trauma; the Adjuncts in Ocular Trauma (AOT) Trial: study protocol for a randomised controlled trial |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1186/1745-6215-14-42 |
| Publisher version: | http://dx.doi.org/10.1186/1745-6215-14-42 |
| Language: | English |
| Additional information: | © 2013 Banerjee et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. PMCID: PMC3599509 |
| Keywords: | Administration, Ophthalmic, Administration, Oral, Anti-Inflammatory Agents, Clinical Protocols, Drug Therapy, Combination, Eye Injuries, Flurbiprofen, Glucocorticoids, Humans, London, Ophthalmic Solutions, Pilot Projects, Prednisolone, Research Design, Single-Blind Method, Time Factors, Treatment Outcome, Triamcinolone Acetonide, Vitreoretinal Surgery, Vitreoretinopathy, Proliferative |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1389832 |
Archive Staff Only
 |
View Item |
